471 results on '"Ko, Jean Y."'
Search Results
2. Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use
3. Association of Medicaid Expansion Under the Affordable Care Act With Medicaid Coverage in the Prepregnancy, Prenatal, and Postpartum Periods
4. Association between thromboembolic events and COVID-19 infection within 30 days: a case–control study among a large sample of adult hospitalized patients in the United States, March 2020–June 2021
5. Mental health and substance use disorders at delivery hospitalization and readmissions after delivery discharge
6. Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017.
7. Obstetrician-gynecologists' practices and attitudes on substance use screening during pregnancy.
8. Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018
9. Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States
10. Changes in rates of adverse pregnancy outcomes during the COVID-19 pandemic: a cross-sectional study in the United States, 2019–2020
11. Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder
12. Illness severity indicators in newborns by COVID-19 status in the United States, March–December 2020
13. Racial and Ethnic Differences in Parental Attitudes and Concerns About School Reopening During the COVID-19 Pandemic — United States, July 2020
14. Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020
15. COVID-19 Mitigation Behaviors by Age Group — United States, April–June 2020
16. Characteristics of Marijuana Use During Pregnancy — Eight States, Pregnancy Risk Assessment Monitoring System, 2017
17. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM — 15 Hospitals, Massachusetts, 2017
18. Vital Signs : Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
19. Vital Signs : Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression — United States, 2018
20. Update : Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020
21. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis
22. Frequency of cannabis use during pregnancy and adverse infant outcomes, by cigarette smoking status – 8 PRAMS states, 2017
23. Mental Health of Parents and Primary Caregivers by Sex and Associated Child Health Indicators
24. Current marijuana use among women of reproductive age
25. Effectiveness of two systems-level interventions to address perinatal depression in obstetric settings (PRISM): an active-controlled cluster-randomised trial
26. Hospitalization With Cardiovascular Conditions in the Postpartum Year Among Commercially Insured Women in the U.S.
27. Opioid Use Disorder Documented at Delivery Hospitalization—United States, 1999–2014
28. Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013–2019
29. Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
30. Timing of Postpartum Depressive Symptoms
31. National Trends in Hepatitis C Infection by Opioid Use Disorder Status Among Pregnant Women at Delivery Hospitalization — United States, 2000–2015
32. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome
33. Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome — Six States, 2013–2017
34. Prevalence and maternal characteristics associated with receipt of prenatal care provider counseling about medications safe to take during pregnancy
35. Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013–2019.
36. Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014
37. Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study
38. Association Between State Policies on Improving Opioid Prescribing in 2 States and Opioid Overdose Rates Among Reproductive-aged Women
39. CDC Grand Rounds : Public Health Strategies to Prevent Neonatal Abstinence Syndrome
40. Trends in Postpartum Depressive Symptoms — 27 States, 2004, 2008, and 2012
41. Rural/urban differences in health care utilization and costs by perinatal depression status among commercial enrollees
42. Assessing Sustainability of State-Led Action Plans for the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community, 2018–2021
43. Rural/urban differences in health care utilization and costs by perinatal depression status among commercial enrollees.
44. Neonatal Abstinence Syndrome Incidence and Health Care Costs in the United States, 2016
45. Post-COVID conditions and healthcare utilization among adults with and without disabilities—2021 Porter Novelli FallStyles survey
46. Cardiac Arrest During Delivery Hospitalization
47. Incidence of Neonatal Abstinence Syndrome — 28 States, 1999–2013
48. Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak — Puerto Rico, 2016
49. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization--United States, 2017-2019
50. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination--PCORnet, United States, January 2021-January 2022
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.